weekly Review: August 29 - September 2, 2010

Trading on the Tel Aviv Stock Exchange (TASE) during the last week was marked by high volatility and price gains in all leading indices, in keeping with the global trend.

 

The TA-25 index which gained 1.6% over the week is now higher by 1.1% from its level at the beginning of the year, following a 75% increase in 2009.

 

The TA-100 index increased by 1.9% and is now higher by 0.3% from its level at the beginning of this year. This follows a sharp increase of 89% attained in 2009.

 

The Tel Tech-15, index of large technology companies, affected by trading on Nasdaq, rose by 3.1%. The Real Estate-15 index gained 1.2% and the Finance index almost remained unchanged.

 

Shares of the U.S biomed firm, Protalix BioTherapeutics, Inc. has been approved for listing on the Tel Aviv Stock Exchange, trading will start on September 6, 2010. The company is already traded on NYSE AMEX and joins the 45 companies dually-listed on major U.S. exchanges and TASE.

 

Figures released by Israel’s Central Bureau of Statistic indicate that unemployment rate in the second quarter of 2010 dropped to 6.2%, compared to 7.0% in the previous quarter and to 7.6% - the average in 2009.